Medical innovations like precision medicine, cell and gene therapy, and immuno-oncology fuel new ways of preventing and detecting various diseases and creating tailwinds for the pharmaceutical industry. In addition, technology is powering the industry in activities like drug discovery, manufacturing, and commercialization.
Given their solid fundamentals and high profitability, I believe these pharma stocks, Johnson & Johnson (JNJ), Eli Lilly and Company (LLY), and Dr. Reddy's Laboratories Limited (RDY), should be a part of every investor’s portfolio.
